Form 4: Geron Corp EVP, Chief Financial Officer Michelle Robertson Reports Stock Option and Restricted Stock Unit Grants

Michelle Robertson, EVP and Chief Financial Officer of Geron Corporation, reports the acquisition of stock options and restricted stock units.

Summary

• On February 18, 2025, Michelle Robertson, the EVP and Chief Financial Officer of Geron Corporation, was granted stock options to purchase 656,000 shares of common stock at an exercise price of $2.63.
• These options vest in 48 consecutive equal monthly installments starting from the grant date, contingent upon continued service to the Issuer.
• Robertson also received 110,000 restricted stock units (RSUs), each representing the right to receive one share of Geron's common stock.
• The RSUs vest in four consecutive equal annual installments from the grant date, also contingent upon continued service.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The grant of equity-based compensation is a standard practice and generally viewed favorably as it aligns management's interests with shareholders. There are no explicitly negative aspects presented in the document.

Positives

• The grant of stock options and RSUs to the CFO aligns her interests with those of the shareholders, incentivizing her to contribute to the company's long-term success.
• The vesting schedules of both the options and RSUs encourage continued service and commitment from the CFO.

Future Outlook

The document does not contain specific forward-looking statements beyond the vesting schedules of the granted securities.

Industry Context

Stock option and RSU grants are a common form of executive compensation in the biotechnology industry, used to attract and retain talent and align management's interests with those of shareholders.

Comparison to Industry Standards

• Executive compensation packages, including stock options and RSUs, are standard practice in the biotech industry.
• Companies like Gilead Sciences, Amgen, and Biogen also utilize similar equity-based compensation to incentivize their executives.
• The specific number of shares and vesting schedules would need to be compared against peer companies of similar market capitalization and stage of development to determine if they are in line with industry norms.

Stakeholder Impact

• Shareholders: The grants align management's interests with shareholder value creation.
• Employees: The grants can improve morale and retention by incentivizing key personnel.
• Company: The grants can help attract and retain top talent.

Key Dates